Kimberly-Clark offers remedies in bid for EU approval of Kenvue deal
来源：Reuters发布于 2026-09-23
Kimberly-Clark has offered concessions to address EU antitrust concerns about its $40 billion bid for Tylenol maker Kenvue , a filing on the European Commission website showed on Wednesday.
本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。